Advances in breast cancer therapy

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Philadelphia [u.a.] Saunders 1999
Schriftenreihe:Hematology, oncology clinics of North America 13,2
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV012616415
003 DE-604
005 20150204
007 t
008 990621s1999 ad|| |||| 00||| eng d
035 |a (OCoLC)247591306 
035 |a (DE-599)BVBBV012616415 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-19  |a DE-355  |a DE-12  |a DE-29  |a DE-578 
084 |a YC 1700  |0 (DE-625)153192:  |2 rvk 
245 1 0 |a Advances in breast cancer therapy  |c George W. Sledge guest ed. 
264 1 |a Philadelphia [u.a.]  |b Saunders  |c 1999 
300 |a X S., S. 311 - 475  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Hematology, oncology clinics of North America  |v 13,2 
650 0 7 |a Therapie  |0 (DE-588)4059798-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Brustkrebs  |0 (DE-588)4008528-4  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)4143413-4  |a Aufsatzsammlung  |2 gnd-content 
689 0 0 |a Brustkrebs  |0 (DE-588)4008528-4  |D s 
689 0 1 |a Therapie  |0 (DE-588)4059798-2  |D s 
689 0 |5 DE-604 
700 1 |a Sledge, George W.  |e Sonstige  |0 (DE-588)142615749  |4 oth 
830 0 |a Hematology, oncology clinics of North America  |v 13,2  |w (DE-604)BV000625446  |9 13,2 
856 4 2 |m HBZ Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008569582&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
999 |a oai:aleph.bib-bvb.de:BVB01-008569582 

Datensatz im Suchindex

_version_ 1804127270039715840
adam_text ADVANCES IN BREAST CANCER THERAPY CONTENTS Preface ix George W. Sledge, Jr The Biology of Breast Cancer 311 Sharyl J. Nass and Nancy E. Davidson One of the most widely used and effective treatments for breast cancer is the anti estrogen tamoxifen. The efficacy of this hor¬ monal therapy can be explained by the dependence of many breast tumors on estrogen for growth and survival. Like estrogen, many other hormones and growth factors are known to play a role in normal breast development, and also have been proposed as factors in the origin of breast cancer. A better understanding of the contribution of these factors to breast neoplasia may pro¬ vide the impetus for developing new therapies to combat inherent or acquired resistance to anti estrogens, which is common. Advances in Breast Imaging 333 Handel E. Reynolds Many exciting developments are occurring in breast imaging. Digital mammography holds the promise of telemammography and computer aided diagnosis. Mammoscintigraphy may be help¬ ful in identifying drug resistant rumors before therapy. There is renewed interest in evaluating ultrasound as a potential ad junctive screening tool in women with radiographically dense breasts. Finally, contrast enhanced magnetic resonance imaging may be used more extensively in the monitoring of tumor re¬ sponse to primary chemotherapy and in the preoperative work up of patients being considered for breast conservation therapy. H1MATOLOGY/QNCOLOGY CLINICS OF NORTH AMERICA VOLUME 13 • NUMBER 2 • APRIL 1999 V Lymphatic Mapping in Breast Cancer 349 Emilia L. Dauway, Rosemary Giuliano, Fadi Haddad, Solange Pendas, Damon Costello, Charles E. Cox, Claudia Berman, Ni Ni Ku, and Douglas S. Reintgen The most accurate predictor of survival in breast cancer is the presence or absence of lymph node metastases. Lymphatic map¬ ping with sentinel node biopsy is a new technique that provides more accurate nodal staging compared with routine histology for women with breast cancer, but without the morbidity of a com¬ plete lymph node dissection. Sentinel lymph node (SLN) biopsy is a more conservative approach to the axilla that requires close collaboration from the surgical team, nuclear medicine, and pa¬ thology. National trials are investigating the clinical relevance of the upstaging that occurs with a more intense examination of the SLN. As is the case with breast preservation as a viable alternative to mastectomy for the definitive treatment of the primary node, selective lymphadenectomy has the ability to decrease morbidity without compromising patient care. An Update on Radiation Therapy in Breast Cancer 373 Silvia Formenti and Garth Green Radiation therapy plays an important role in the management of both invasive and noninvasive breast cancer. During the last 20 years, the availability of radiation therapy has made it possible to test the feasibility and safety of breast preservation after the diagnosis of early stage breast cancer. This article summarizes some of the ongoing controversies concerning the use of radiation therapy in the multidisciplinary management of breast cancer. Adjuvant Therapy for Resectable Breast Cancer 391 Pamela N. Miinster and Clifford A. Hudis The breast cancer mortality rate is falling, most likely because of a combination of early detection, refined surgical and radiation therapy techniques, and improved systemic therapy efficacy. The proper integration and application of these treatment modalities present evolving challenges for clinicians. Systemic therapy, in particular, is changing rapidly with the advent of new chemother¬ apy drugs, new classes of agents, and new therapeutic regimens. The most recent studies suggest that optimal outcomes are possi¬ ble through the broad but appropriate use of hormone therapy and chemotherapy to prevent relapse and possibly prevent second primary tumors. The choice of therapy for patients remains a matter for careful consideration and discussion in each individual case. The Role of Chemotherapy for Metastatic Breast Cancer 415 Kathy D. Miller and George W. Sledge, Jr Metastatic breast cancer remains a cause of considerable morbid¬ ity and mortality and probably accounted for 43,900 deaths in the vi CONTENTS United States in 1998. The last decade has seen an increase of new chemotherapeutic agents with significant activity. The tax anes have become the salvage therapy of choice, particularly in patients who received anthracycline based adjuvant therapy. Questions of the optimal duration of therapy and the importance of dose intensity continue to be debated, but have been clarified by recent trials. Continued research to develop novel drugs and biologic therapies offers hope for future patients. Hormonal Therapy for Breast Cancer: An Update 435 William J. Gradishar and V. Craig Jordan The use of endocrine manipulation for the treatment of breast cancer has been available for 100 years, but in recent years the number of therapeutic options available to patients has increased dramatically. This article considers new developments in the use of hormonal agents for the treatment and prevention of breast cancer. Locally Advanced Breast Cancer 457 Francisco J. Esteva and Gabriel N. Hortobagyi The multidisciplinary management of patients with locally ad¬ vanced breast cancer (LABC) has evolved over the last three decades. The introduction of chemotherapy (CT) and endocrine therapy in conjunction with surgery and radiation therapy (XRT) have changed the natural history of this disease. The authors discuss the role of the taxanes, novel endocrine therapy, and high dose CT programs in the management of LABC. Indications for breast conserving surgery are presented. The role of prognostic and predictive tumor markers in LABC is discussed. Index 473 Subscription Information Inside back cover CONTENTS Vli
any_adam_object 1
author_GND (DE-588)142615749
building Verbundindex
bvnumber BV012616415
classification_rvk YC 1700
ctrlnum (OCoLC)247591306
(DE-599)BVBBV012616415
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01499nam a2200361 cb4500</leader><controlfield tag="001">BV012616415</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150204 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">990621s1999 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)247591306</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012616415</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 1700</subfield><subfield code="0">(DE-625)153192:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in breast cancer therapy</subfield><subfield code="c">George W. Sledge guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Saunders</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X S., S. 311 - 475</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Hematology, oncology clinics of North America</subfield><subfield code="v">13,2</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sledge, George W.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)142615749</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Hematology, oncology clinics of North America</subfield><subfield code="v">13,2</subfield><subfield code="w">(DE-604)BV000625446</subfield><subfield code="9">13,2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=008569582&amp;sequence=000002&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008569582</subfield></datafield></record></collection>
genre (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet Aufsatzsammlung
id DE-604.BV012616415
illustrated Illustrated
indexdate 2024-07-09T18:30:40Z
institution BVB
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-008569582
oclc_num 247591306
open_access_boolean
owner DE-19
DE-BY-UBM
DE-355
DE-BY-UBR
DE-12
DE-29
DE-578
owner_facet DE-19
DE-BY-UBM
DE-355
DE-BY-UBR
DE-12
DE-29
DE-578
physical X S., S. 311 - 475 Ill., graph. Darst.
publishDate 1999
publishDateSearch 1999
publishDateSort 1999
publisher Saunders
record_format marc
series Hematology, oncology clinics of North America
series2 Hematology, oncology clinics of North America
spelling Advances in breast cancer therapy George W. Sledge guest ed.
Philadelphia [u.a.] Saunders 1999
X S., S. 311 - 475 Ill., graph. Darst.
txt rdacontent
n rdamedia
nc rdacarrier
Hematology, oncology clinics of North America 13,2
Therapie (DE-588)4059798-2 gnd rswk-swf
Brustkrebs (DE-588)4008528-4 gnd rswk-swf
(DE-588)4143413-4 Aufsatzsammlung gnd-content
Brustkrebs (DE-588)4008528-4 s
Therapie (DE-588)4059798-2 s
DE-604
Sledge, George W. Sonstige (DE-588)142615749 oth
Hematology, oncology clinics of North America 13,2 (DE-604)BV000625446 13,2
HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008569582&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle Advances in breast cancer therapy
Hematology, oncology clinics of North America
Therapie (DE-588)4059798-2 gnd
Brustkrebs (DE-588)4008528-4 gnd
subject_GND (DE-588)4059798-2
(DE-588)4008528-4
(DE-588)4143413-4
title Advances in breast cancer therapy
title_auth Advances in breast cancer therapy
title_exact_search Advances in breast cancer therapy
title_full Advances in breast cancer therapy George W. Sledge guest ed.
title_fullStr Advances in breast cancer therapy George W. Sledge guest ed.
title_full_unstemmed Advances in breast cancer therapy George W. Sledge guest ed.
title_short Advances in breast cancer therapy
title_sort advances in breast cancer therapy
topic Therapie (DE-588)4059798-2 gnd
Brustkrebs (DE-588)4008528-4 gnd
topic_facet Therapie
Brustkrebs
Aufsatzsammlung
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008569582&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link (DE-604)BV000625446
work_keys_str_mv AT sledgegeorgew advancesinbreastcancertherapy